Epidemiological and Clinical Characteristics of Hospitalized Pediatric Patients with SARS-CoV-2 Infection in Mexico City, Mexico

Table 2

Comparison of symptoms between SARS-CoV-2 positive and negative pediatric patients.

Symptom	SARS-CoV-2 positive, n = 36	SARS-CoV-2 negative, n = 85	value
Dyspnoea	8 (22.2%)	27 (31.8%)	0.2
Headache	11 (30.6%)	27 (31.8%)	0.8
Fever	33 (91.7%)	60 (70.6%)	0.01
Cough	17 (47.2%)	39 (45.9%)	0.8
Sore throat	9 (25.0%)	17 (20.0%)	0.5
Tachycardia	4 (11.1%)	12 (14.1%)	0.6
Rhinorrhea	11 (30.6%)	31 (36.5%)	0.5
Nasal congestion	2 (5.6%)	0 (0.0%)	0.1
Tachypnea	7 (19.4%)	15 (17.6%)	0.8
Diarrhea	7 (19.4%)	20 (23.5%)	0.6
Vomiting	13 (15.3%)	4 (11.1%)	0.5
Myalgia	7 (19.4%)	18 (21.2%)	0.8
Fatigue	8 (22.2%)	7 (8.2%)	0.03
Hypoemia	3 (8.3%)	2 (2.4%)	0.1
Chest pain	3 (8.3%)	2 (2.4%)	0.1

>38.2 Celsius at the level of the axilla, ranges do not vary with age.Tachycardia cutoff: 1–<12 months old (>190 beats/min); 1–<3 years old (>140 beats/min); 3–<6 years old (> 120 beats/min); 6–11 years old (>118 beats/min); and ≥12 years old (>100 beats/min).Tachypnea cutoff: <1 year old (>53 breaths/min); 1–<3 years old (>37 breaths/min); 3–6 years old (>28 breaths/min); 6–11 years old (>25 breaths/min); and ≥ 12 years old (>20 m breaths/min). Significant values are bolded.